Quarter Financial Results

 
News Articles for Quarter Financial Results top ^
2013/4/22
http://media.marketwire.com/attachments/201207/66682_logostm.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1009630&ProfileId=051205&sourceType=1 GENEVA --
Sign-up for STMicroelectronics Reports 2013 First Quarter Financial Results investment picks
2013/4/25
ATLANTA, April 25, 2013 (GLOBE NEWSWIRE) -- State Bank Financial Corporation (Nasdaq:STBZ) today announced unaudited financial results for the quarter ended March 31, 2013.
Sign-up for State Bank Reports First Quarter Financial Results; Positive Fundamental Trends Obscured by Timing of Revenue Recognition investment picks
2013/3/7
Daegis (NASDAQ:DAEG) , an eDiscovery and information management company, today announced financial results for its fiscal 2013 third quarter, ended January 31, 2013.
Sign-up for Daegis Inc. Reports Fiscal 2013 Third Quarter Financial Results investment picks
2013/2/28
MALVERN, Pa.
Sign-up for Endo Reports Fourth Quarter Financial Results And Reaffirms 2013 Financial Guidance investment picks
2013/2/5
New ACOG Practice Bulletin Highlights Hysteroscopic Sterilization for the First Time MOUNTAIN VIEW, Calif., Feb.
Sign-up for Conceptus(R) Reports Fourth Quarter Financial Results and Introduces 2013 Financial Guidance investment picks
2013/2/19
Reports 22.8% Increase in Revenue Upgrade of the Existing Coking Facility Reduces Dependency on High Cost Raw Coal and Improves Margins PINGDINGSHAN, China , Feb.
Sign-up for SinoCoking Coal and Coke Chemical Industries Announces Fiscal 2013 Second Quarter Financial Results investment picks
2013/2/28
KILGORE, Texas, Feb.
Sign-up for Martin Midstream Partners Reports 2012 Quarterly Financial Results by Reportable Business Segment investment picks
2013/2/28
Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results Canada NewsWire MONTREAL, Feb.
Sign-up for Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results investment picks
2013/2/28
MONTREAL , Feb.
Sign-up for Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results investment picks
2013/2/4
Company to Hold Conference Call on February 5, 2013, at 8 a.m. ET BEIJING , Feb.
Sign-up for ATA Reports Fiscal 2013 Third Quarter Financial Results investment picks
2013/2/14
http://media.marketwire.com/attachments/201102/21554_craylogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=986220&ProfileId=051205&sourceType=1 SEATTLE, WA --
Sign-up for Cray Reports 2012 Full Year and Fourth Quarter Financial Results investment picks
2013/2/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0853372001&sourceType=1 http://www.ccnmatthews.com/logos/20090601-PNILARGE.gif VANCOUVER, BRITISH COLUMBIA --
Sign-up for PNI Digital Media Reports Fiscal 2013 First Quarter Financial Results investment picks
2013/1/31
- Record high revenue of $143 million supports continued long-term strategic growth investments - Test productivity gains drove higher revenue and EPS of $0.87, higher than the previously communicated outlook for the quarter - MTS reaffirms previous fiscal 2013 outlook for revenue and EPS growth rates in the 5 to 10 percent range EDEN PRAIRIE, Minn.
Sign-up for MTS Reports Fiscal 2013 First Quarter Financial Results investment picks
2013/2/13
http://media.marketwire.com/attachments/201107/2205_CCA.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=985606&ProfileId=051205&sourceType=1 NASHVILLE, TN --
Sign-up for CCA Announces 2012 Fourth Quarter Financial Results investment picks
2013/2/13
Achieves Record Quarterly Revenue and Gross Profit BrightPoint Contributes $1 Billion to Revenues and is 4 Cents Accretive to EPS, Excluding Acquisition Related Costs SANTA ANA, Calif.
Sign-up for Ingram Micro Reports 2012 Fourth Quarter Financial Results investment picks
2013/2/13
Arrowhead Research Corporation (NASDAQ: ARWR) , a targeted therapeutics company, today announced financial results for its fiscal 2013 first quarter ended December 31, 2012.
Sign-up for Arrowhead Reports Fiscal 2013 First Quarter Financial Results investment picks
2013/2/25
Reduces 2013 Earnings Guidance and Revises Three-year Financial Forecasts TULSA, Okla.
Sign-up for ONEOK Announces Full-year 2012 and Fourth-quarter Financial Results investment picks
2013/1/30
Cardiovascular Systems, Inc. (Nasdaq: CSII) : Revenues of $25.3 million rose 28 percent over the fiscal 2012 second quarter, and 9 percent sequentially over the fiscal 2013 first quarter Stealth 360° ® revenues increased to 93 percent of total device revenues Office-based lab revenues continued to grow at a double-digit consecutive quarter rate ORBIT II coronary trial enrollment has been completed PMA submission of module 3, which includes ORBIT II clinical data, is expected to occur around March 31, 2013 Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal second quarter ended December 31, 2012.
Sign-up for Cardiovascular Systems Reports Fiscal 2013 Second-Quarter Financial Results investment picks
2013/1/29
ATLANTA , Jan.
Sign-up for Concurrent Reports Fiscal Year 2013 Second Quarter Financial Results investment picks
2013/1/29
HONOLULU , Jan.
Sign-up for Hawaiian Holdings Reports 2012 Full Year and Fourth Quarter Financial Results investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Quarter Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Quarter Ffo  |  Next: Quarter Full-Year